Google Offers Foundation Medicine’s Cancer Tests


 Google Offer Foundation Medicine

Google will quickly begin overlaying the cost of basis drugs’ DNA checks for employees and their household-individuals affected by most cancers, as part of its well being advantages portfolio.

Foundation medication’s chief govt Michael Bellini gave a nod to the care for Google all over a company revenue call on Wednesday, in keeping with a person who listened in. Bellini mentioned Google staff have been made aware of this new benefit last week.

Google declined to comment.

Foundation medication helps steer oncologists to a drug remedy in line with the patient’s genetic profile. Its two commercially on hand exams vary from $5,800 to $7,200.

Google to Offer Foundation Medicine’s Cancer Tests as Latest Health Benefit

Google will start masking these checks in January, 2015.

This move from Google follows an announcement from Silicon Valley tech companies apple and facebook that they might start covering the cost of egg freezing for female staff.

In Silicon Valley, where software developers are in brief provide, firms are competing to supply new well being advantages as a key means to recruit and continue ability.

Google’s funding arm Google Ventures has prior to now invested in foundation drugs. Google Ventures’ accomplice Krishna Yes want sits on basis medicine’s board.

Comments are closed.